/PRNewswire/ The Lung Cancer Research Foundation (LCRF) is pleased to announce the appointment of a select group of volunteers to its newly formed Education.
Study met primary endpoint, demonstrating a higher proportion of sustained platelet response with VYVGART treatment compared to placebo ; responders observed across patient types regardless of prior. | May 5, 2022